GHRHR
protein-codinggrowth hormone releasing hormone receptor, the group of Glucagon receptor family
Gene summary
This gene encodes a receptor for growth hormone-releasing hormone. Binding of this hormone to the receptor leads to synthesis and release of growth hormone. Mutations in this gene have been associated with isolated growth hormone deficiency (IGHD), also known as Dwarfism of Sindh, a disorder characterized by short stature. [provided by RefSeq, Jun 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032567
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032567
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013006
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Clinical Genomic Database (CGD)
Manifestation: Endocrine
Intervention: Endocrine
Rationale: Combined treatment of GH and GNRHa can be effective in increasing final height, even in the case of advanced bone age and pubertal stage, though consideration related to cardiovascular-related treatment effects may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GHRHR variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000823.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 74 | 2 | 82 | |
| missense | 4 | 11 | 101 | 15 | 131 | |
| nonsense | 6 | 2 | 8 | |||
| start loss | 1 | 1 | ||||
| frameshift | 6 | 4 | 2 | 12 | ||
| splice donor/acceptor (+/-2bp) | 6 | 3 | 1 | 10 | ||
| Total | 22 | 21 | 110 | 89 | 2 | 244 |
Highest pathogenic variant AF is 0.0002051619
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000814.2 | 13 | MANE Select | |
| Ensembl | ENSP00000320180.2 | 13 | MANE Select | |
| Ensembl | ENSP00000338184.4 | 2 | Standard | |
| Ensembl | ENSP00000379529.2 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuroactive ligand-receptor interaction - Homo sapiens (human)
- GPCRs, Other
- GPCRs, Class B Secretin-like
- Signaling by GPCR
- Signal Transduction
Biological Process
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- activation of adenylate cyclase activity
- lactation
Molecular Function
- G protein-coupled receptor activity
- protein binding
- G protein-coupled peptide receptor activity
- growth hormone-releasing hormone receptor activity
- peptide hormone binding
Cellular Component
- nuclear inner membrane
- nuclear outer membrane
- cytoplasm
- plasma membrane
- cell surface
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000326139
- Coding exons
- 13
- Length
- 54586
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 26
- Defined
- 125748
- p
- 0.000103
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.497 | 262 | 240 | 1.09 | 0.0000148 | 2733 |
| Missense (PolyPhen) | 88 | 86.55 | 1.0168 | 1110 | ||
| Synonymous | -1.77 | 121 | 98.7 | 1.23 | 0.00000643 | 845 |
| Loss of Function | 1.82 | 15 | 24.8 | 0.605 | 0.00000129 | 256 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor for GRF, coupled to G proteins which activate adenylyl cyclase. Stimulates somatotroph cell growth, growth hormone gene transcription and growth hormone secretion.;
Recessive Scores
- pRec
- 0.223
Intolerance Scores
- LoFtool
- 0.824
- RVIS EVS
- -0.29
- RVIS percentile EVS
- 33.42
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.223
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |